Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-11,934
Closed -$1M 293
2023
Q3
$1M Sell
11,934
-597
-5% -$67.3K 0.31% 83
2023
Q2
$1.59M Sell
12,531
-45
-0.4% -$5.44K 0.61% 37
2023
Q1
$1.42M Sell
12,576
-476
-4% -$53.3K 0.58% 40
2022
Q4
$1.39M Buy
13,052
+164
+1% +$18K 0.58% 38
2022
Q3
$1.09M Hold
12,888
0.87% 25
2022
Q2
$1.06M Sell
12,888
-640
-5% -$58.4K 0.87% 25
2022
Q1
$1.49M Sell
13,528
-64
-0.5% -$7K 1% 21
2021
Q4
$1.47M Buy
+13,592
New +$1.95M 0.96% 22

Other funds holding DXCM

Ignite Planners's DXCM Position: Q4 2023 in Review

Ignite Planners sold out of DexCom (DXCM) in Q4 2023, closing a stake of 11,934 shares — an estimated $1M sold.

Ignite Planners first reported a position in DXCM in Q4 2021 and held it in 8 quarters. The position peaked at $1.59M in Q2 2023. 974 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Ignite Planners reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • Ignite Planners sold 11,934 DexCom shares in Q4 2023, an estimated $1M.
  • Ignite Planners first reported a position in DexCom in Q4 2021 and held it in 8 quarters.
  • Ignite Planners's DexCom position peaked at $1.59M in Q2 2023.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Ignite Planners's 13F filing for Q4 2023, filed 9 Jan 2024.